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Abstract
Background
Sexually transmitted infections (STIs) and bacterial vaginosis (BV) are associated with
increased transmission of HIV, and poor reproductive and sexual health. The burden of
STIs/BV among young people is unknown in many high HIV prevalence settings. We con-
ducted an acceptability, feasibility, and prevalence study of home-based sampling for STIs/
BV among young men and women aged 15–24 years old in a health and demographic sur-
veillance site (HDSS) in rural KwaZulu-Natal, South Africa.
Methods and findings
A total of 1,342 young people, stratified by age (15–19 and 20–24 years) and sex were
selected from the HDSS sampling frame; 1,171/1,342 (87%) individuals had1 attempted
home visit between 4 October 2016 and 31 January 2017, of whom 790 (67%) were suc-
cessfully contacted. Among the 645 who were contacted and eligible, 447 (69%) enrolled.
Consenting/assenting participants were interviewed, and blood, self-collected urine (men),
and vaginal swabs (women) were tested for herpes simplex virus type 2 (HSV-2), chla-
mydia, gonorrhoea, syphilis, trichomoniasis, and BV. Both men and women reported that
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sample collection was easy. Participants disagreed that sampling was painful; more than
half of the participants disagreed that they felt anxious or embarrassed. The weighted preva-
lence of STIs/BV among men and women, respectively, was 5.3% and 11.2% for chlamydia,
1.5% and 1.8% for gonorrhoea, 0% and 0.4% for active syphilis, 0.6% and 4.6% for tricho-
moniasis, 16.8% and 28.7% for HSV-2, and 42.1% for BV (women only). Of the women with
1 curable STI, 75% reported no symptoms. Factors associated with STIs/BV included hav-
ing older age, being female, and not being in school or working. Among those who partici-
pated in the 2016 HIV serosurvey, the prevalence of HIV was 5.6% among men and 19%
among women. Feasibility was impacted by the short study duration and the difficulty finding
men at home.
Conclusions
A high prevalence of STIs/BV was found in this rural setting with high HIV prevalence in
South Africa. Most STIs and HIV infections were asymptomatic and would not have been
identified or treated under national syndromic management guidelines. A nested STI/BV
survey within a HDSS proved acceptable and feasible. This is a proof of concept for popula-
tion-based STI surveillance in low- and middle-income countries that could be utilised in the
evaluation of STI/HIV prevention and control programmes.
Author summary
Why was this study done?
• Adolescents and young adults are particularly vulnerable to sexually transmitted infec-
tions (STIs).
• The first strategic direction of the WHO Global Health Sector Strategy on Sexually
Transmitted Infections 2016–2021 is to collect information on STI prevalence and inci-
dence across representative populations.
• There is evidence that bacterial vaginosis (BV) is a risk factor for poor birth outcomes
and STIs including HIV. The collection of BV prevalence may therefore also be
important.
• Developing new cohorts for dedicated STI/BV prevalence studies may not be realistic,
particularly in sub-Saharan Africa, where the impact of STIs/BV and their consequences
may be greatest.
• Nesting STI/BV surveys within networks of health and demographic surveillance sites
(HDSSs) would be an efficient way of providing data to better understand STI epidemi-
ology among adolescents and young people in high HIV prevalence settings.
What did the researchers do and find?
• We carried out a nested STI/BV survey among 1,342 adolescent and young people in an
HDSS in KwaZulu-Natal, South Africa, between October 2016 and January 2017.
STI/BV among Young People in South Africa
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• Potential participants were contacted at home and invited to participate.
• Participants were interviewed, and samples were collected for STI/BV testing.
• We showed that this study was feasible within the 3.5-month time period: 1,171/1,342
(87%) individuals had1 attempted home visit, of whom 790 (67%) were successfully
contacted.
• The study was acceptable: among those contacted and eligible, 447/645 (69%) enrolled.
Both men and women reported few problems with sample collection.
• We report a high burden of STIs/BV in this population, particularly of chlamydia (5%
in men and 11% in women), herpes simplex virus type 2 (17% in men and 29% in
women), and BV (42% in women).
What do these findings mean?
• Nested STI/BV surveys in HDSSs can be feasible and acceptable; however, more survey
time is needed to ensure that all potential participants are visited and contacted.
• These studies should be carried out in conjunction with studies to measure STI/BV
prevalence in high-risk populations (e.g., female sex workers) to provide robust preva-
lence estimates.
• These data are essential to advocate, fund, plan, implement, and evaluate interventions
for STI prevention and control among adolescents and young people.
• Strategies for the prevention and control of chlamydia, herpes simplex virus type 2, and
BV are needed in this population.
Introduction
In 2012, 286 million people aged 12–24 years lived in Africa, accounting for 18% of the global
youth population. By 2040, the number of young people in Africa is projected to increase by
60% to 466 million [1]. Health interventions targeted at this age group are important for cur-
rent and future adult health and for the health of the next generation. This is particularly true
for sexually transmitted infections (STIs), which, when acquired in adolescence, can jeopardise
sexual and reproductive health later in life and, for women, the health of their babies. In low-
and middle-income countries (LMICs), symptomatic STIs are treated by syndromic manage-
ment (presumptive treatment for symptomatic people without the use of laboratory tests) [2],
but most STIs are asymptomatic and go unnoticed and untreated. Both symptomatic and
asymptomatic STIs can cause serious morbidity, including pregnancy complications, cancer,
infertility, and enhanced HIV transmission. Many of these sequelae are preventable if STI test-
ing and treatment is implemented. Moreover, there is growing evidence that the common
reproductive tract condition bacterial vaginosis (BV) is an independent risk factor for HIV
[3,4], and BV-associated microbiota may decrease the efficacy of topical microbicides [5].
High STI prevalence among young people has been observed worldwide and highlights the
critical need for global efforts to improve sexual and reproductive health in this population. In
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an individual participant data meta-analysis of 18 HIV prevention studies among women in
sub-Saharan Africa, STI prevalence was higher among young women aged 15–24 years than
among older women for all STIs except herpes simplex virus type 2 (HSV-2) [6]; in this age
group, the estimated range of prevalence of STIs in South Africa among clinic/community
populations was 8.0% to 20.6% for chlamydia, 1.4% to 8.9% for gonorrhoea, 3.1% to 20.0% for
trichomoniasis, 31.9% to 53.7% for HSV-2, and 35.8% to 52.4% for BV. In addition, viral STIs
such as HSV-2 and human papillomavirus (HPV) infection are often acquired soon after sex-
ual debut, which usually occurs in adolescence, and both are common among young people in
sub-Saharan Africa [7–10]. However, many of the studies yielding these results are conducted
in urban areas and/or clinical cohorts of adolescents and young adults known to be at high
risk of infection. To date, there have been few population estimates of the burden of STIs
among adolescent girls and young women and no studies among men [6].
The WHO Global Health Sector Strategy on Sexually Transmitted Infections 2016–2021
has outlined the goals and targets for global STI prevention and control. The first strategic
direction is to collect information on STI prevalence and incidence across representative pop-
ulations [11]. Understanding regional and national STI epidemics is essential to advocate,
fund, plan, and implement interventions for STI prevention and control. The strategy also
urges LMICs to move from syndromic to aetiologic surveillance of STIs, and to conduct rou-
tine surveillance in key populations most at risk for STIs including adolescents. Yet, in
resource-limited settings, developing new cohorts for dedicated STI prevalence studies may
not be realistic, particularly in sub-Saharan Africa, where the impact of STIs and their conse-
quences may be greatest.
Networks of health and demographic surveillance sites (HDSSs) conducting longitudinal
population-based research such as the International Network for the Demographic Evaluation
of Populations and their Health (INDEPTH Network) may provide opportunities to obtain
representative STI/BV prevalence estimates for adolescents and young people and facilitate
community entry and engagement with sensitive topics such as sexual health [12]. However,
population-based surveys can be challenging to conduct. Key requirements include the accept-
ability of being approached at home and home sampling, the feasibility of finding young peo-
ple at home and a parent available to consent, the receipt of results while maintaining
confidentiality, and establishing clinical pathways for the treatment of cases. We conducted a
study in the Africa Health Research Institute (AHRI; formerly the Africa Centre for Health
and Population Studies) HDSS, a member of the INDEPTH Network, to investigate the
acceptability and feasibility of home-based sampling of STIs/BV among young people aged
15–24 years, and to measure prevalence and factors associated with STIs/BV. The background
2011 HIV prevalence in women aged 15–19 years and 20–24 years was 14.7% and 26.5%,
respectively, and in men aged 15–19 years and 20–24 years was 7.0% and 10.2%, respectively
[13].
Methods
This study is reported as per the Strengthening the Reporting of Observational Studies in Epi-
demiology (STROBE) guidelines (S1 STROBE Checklist) [14].
Setting and sampling
The AHRI HDSS is located in the rural uMkhanyakude district of KwaZulu-Natal, covering an
area of 438 km2, with a 2016 population of approximately 100,000 people who are members of
12,000 households [15]. Since 2000, annual household-based surveys have been used to collect
information on births, deaths, and migration patterns from all household members, including
STI/BV among Young People in South Africa
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non-residents. In addition, resident household members aged15 years are invited to partici-
pate in an annual HIV serosurvey, and to complete a questionnaire on general health and sex-
ual behaviour.
For the STI survey, young men and women who were resident in the HDSS, based on the
data collected in the routine household surveillance, and aged 15–24 years as of 19 July 2016
were eligible for inclusion. A random sample of 1,342 young people was selected to obtain a
target sample size of 800, allowing for 40% non-contact/refusals. This sample size would have
provided acceptable precision for estimating the prevalence of an STI with a prevalence as low
as 1.5%. Sampling was stratified by age group (15–19 years and 20–24 years) and sex. The
HDSS is divided into 14 subareas; within each stratum, a fixed proportion was sampled from
each subarea to reflect the population distribution across the HDSS.
Ethics, informed consent, and community engagement
The University of KwaZulu-Natal Biomedical Research Ethics Committee, the London School
of Hygiene & Tropical Medicine Research Ethics Committee, the Southampton General Hos-
pital Faculty of Medicine Ethics Committee, Hlabisa District Hospital, and the AHRI Som-
khele Community Advisory Board approved the study protocol. The STI survey was called
Ukuvikela impilo yetho yokuzalana eyigugu, isiZulu for ‘protecting our precious reproductive
health’. The AHRI Community Engagement Team disseminated information about the study
in community dialogues and road shows. Potential participants were contacted at home and
invited to participate. Written parental consent was required for participants <18 years old,
with participant written assent. Participants aged 18 years or older proved written consent.
Participants consented separately for each sample type (vaginal swab [women only], urine
[men only], and blood); participants who did not consent for a sample could still enrol in the
study. Participants were asked for permission to link their STI survey data with the data col-
lected in the annual routine household and individual surveillance.
Study procedures
The study team consisted of 2 field workers (1 male and 1 female), 2 female licensed practical
nurses, 1 male licensed practical nurse, and 1 male registered nurse team leader, with an inten-
tion to match a same-sex nurse to participants whenever possible. The field work was con-
ducted Tuesday to Saturday from 11 AM to 7 PM to maximise the chances of finding
participants at home.
After informed consent/assent, the participant had a short computer-assisted personal
interview by the study nurse [16]. The interview obtained data on demographics, substance
use, sexual behaviour, violence, circumcision (men only), family planning (women only), geni-
tal hygiene, and genital symptoms. For questions about sexual behaviour and violence, the par-
ticipant was asked to self-interview using a tablet device; however, the study nurse was
available to support the participant if needed. If a participant reported genital complaints, they
were referred to our study nurse in a local primary health clinic for syndromic management as
per 2015 South African STI management guidelines [17].
All participants had 8.5 ml of blood drawn for syphilis and HSV-2 testing. For women, the
research nurse explained the procedure to self-collect a total of 5 vaginal swabs for testing for
chlamydia, gonorrhoea, trichomoniasis, and BV (an additional swab was collected for storage).
Swab collection took place in a private setting identified by the participant. Men collected a
urine sample for testing for chlamydia, gonorrhoea, and trichomoniasis.
After the sample collection, participants were asked to rate their agreement with 10 state-
ments using a visual analogue scale (VAS) ranging from 0 (easy/agree) to 100 (difficult/
STI/BV among Young People in South Africa
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disagree) to assess the ease of understanding of consent for the study, the instructions for col-
lecting the sample, and the participant’s experience of participation.
All participants were asked to provide contact information for test results, including their
preferred mode of contact for both positive and negative results (e.g., telephone call, SMS mes-
sage, or WhatsApp message), and ideal hours for contact. We attempted to contact all partici-
pants with the results for laboratory-diagnosed curable STIs (chlamydia, gonorrhoea,
trichomoniasis, and syphilis). All participants with mobile phones were given 5 South African
rand (US$0.37) of air time to contact the study nurses with questions if needed. Participants
who had a positive test for a curable STI were referred for free treatment; reimbursement for
travel was provided. We traced all cases who were not contactable or did not come to clinic for
treatment. We used British Association for Sexual Health and HIV guidelines for the treatment
of laboratory-diagnosed chlamydia, gonorrhoea, and trichomoniasis [18–20], and South Afri-
can STI management guidelines for the treatment of syphilis [17].
Laboratory methods
Laboratory testing was performed according to manufacturers’ instructions and standard
operating procedures in the central AHRI laboratory and Global Clinical and Viral Laboratory
in Durban, South Africa. Serum samples were used to test for IgG antibodies for HSV-2 by a
type-specific ELISA (Kalon Biological, Guildford, UK). Syphilis infection was determined by
the Determine Syphilis TP rapid test (Alere, Waltham, MA, US) in the central AHRI labora-
tory. All positives were confirmed at the Global Clinical and Viral Laboratory with Treponema
pallidum haemagglutination (TPHA) (Randox Laboratories, Crumlin, UK) and tested with the
Venereal Disease Research Laboratory (VDRL) test (Omega Diagnostics, Alva, UK) using a
reverse algorithm as per South African STI management guidelines [17] due to the young age
of participants (i.e., unlikely to have treated past infections). Syphilis infection was defined as
follows: negative, TPHA−/VDRL−; early or previously treated infection, TPHA+/VDRL−; and
active syphilis, TPHA+/VDRL+ low titre [<1:8] or TPHA+/VDRL+ high titre [1:8].
Vaginal swabs were used to prepare a slide at the home and air dried. Slides were trans-
ported to the central AHRI laboratory, methanol-affixed, Gram stained, and examined for BV
using the Nugent score [21]. A Nugent score of 0–3 indicated normal microbiota, 4–6 indicated
intermediate microbiota, and 7–10 indicated BV. Vaginal swabs (women) and urine (men)
were sent to Global Clinical and Viral Laboratory for testing by real-time PCR for Neisseria
gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis. Detection was carried out
using the Lightmix Kit Neisseria gonorrhoeae, the Lightmix Kit Chlamydia trachomatis, and the
Lightmix Kit Trichomonas vaginalis (TIB MOLBIOL, Berlin, Germany) following the manufac-
turer’s instructions. All positive tests for N. gonorrhoeae were confirmed using GeneXpert
(Cepheid, Sunnyvale, CA, US). The confirmation test should have a higher specificity than the
first test; the GeneXpert N. gonorrhoeae detection probe has 2 primer sets that increase the spec-
ificity needed for the N. gonorrhoeae confirmation [22,23]. External quality controls were car-
ried out quarterly for real-time PCR with the College of American Pathologists.
Data management and statistical methods
Data were captured electronically using REDCap software [24]. Range and consistency checks
were done automatically during data capture; further data cleaning and analysis was done
using Stata 14 (College Station, TX, US). All questions required a response to minimise miss-
ing data, although participants could reply ‘don’t know’ or ‘prefer not to say’.
The statistical analysis plan was prepared prior to the statistical analysis (S1 Analysis).
Changes in response to peer review of this paper included the inclusion of other STIs in the
STI/BV among Young People in South Africa
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BV risk factor analysis, and the inclusion of transactional sex in each risk factor analysis. Con-
tinuous variables were summarised using means and standard deviations or medians and
interquartile ranges; categorical data were summarised using frequency counts and percent-
ages. Missing data were not imputed.
The acceptability and feasibility of our survey were measured by the following outcomes:
proportion of participants who were selected and contactable, the proportion of those con-
tacted who agreed to participate, the proportion who agreed to each sample collection (e.g.,
blood, vaginal swabs, and urine), median and interquartile range of responses to a VAS mea-
suring acceptability post-sampling, and proportion of cases who presented for treatment. We
also estimated STI/BV prevalence and explored factors associated with any curable STI (chla-
mydia, gonorrhoea, syphilis, and trichomoniasis), HSV-2, and BV.
The number of individuals who were successfully contacted and who consented to partici-
pate were tabulated by sex, age group, residence location (urban/peri-urban/rural), household
socioeconomic status, education level, and HIV status using linked data from the HDSS. Char-
acteristics of individuals who participated and the remainder in the eligibility list were com-
pared using chi-squared tests.
The prevalence estimate of each STI or BV, and its 95% confidence interval, was calculated
overall and by sex; prevalence estimates were weighted to account for the stratified sample
design and non-response, calculated as the inverse probability of study participation in strata
defined by age group, sex, and residence location (urban/peri-urban/rural). We compared
these results to unweighted prevalence and prevalence weighted for the stratified sample
design only.
Logistic regression was used to estimate odds ratios and 95% CIs for factors associated with
the presence of any curable STI (chlamydia, gonorrhoea, syphilis, or trichomoniasis), of HSV-
2, and of BV; separate models were developed for each outcome. Potential factors associated
with curable STIs, HSV-2, and BV were examined using a conceptual framework with 3 levels:
sociodemographic factors, modifiable behavioural factors (including genital hygiene), and sex-
ual behaviour and violence. For each outcome, age and sex (except for BV, which was in
women only) were considered a priori confounders and were included in all models. Sociode-
mographic factors whose age- and sex-adjusted associations with the outcome were significant
at P< 0.10 were included in a multivariable model; those remaining associated at P< 0.10
were retained in a core model. Behavioural factors were then added to this core model one by
one; those that were associated with the outcome at P< 0.10, after adjusting for sociodemo-
graphic factors, were included in a multivariable model and retained if they remained associ-
ated at P< 0.10. Associations with sexual behavioural and violence factors were subsequently
determined in a similar way. Many of the questions about sexual relationships were asked only
if participants reported having ever had sex, so analyses of these variables were restricted to
that subgroup.
Results
Acceptability and feasibility
The field work took place from 4 October 2016 to 31 January 2017. Due to unexpected time
limitations, only 1 visit attempt per selected individual was carried out from November to Jan-
uary to attempt coverage in subareas (a total of 14 subareas), but not all selected young people
were visited. Among the 1,342 individuals selected, 1,171 (87%) had1 attempted home visit,
of whom 781 (67%) were successfully contacted (Fig 1). Of those who were contacted, 645
(83%) were still eligible. Among those contacted and eligible, 447 (69%) enrolled. Individuals
aged 20–24 years were less likely to be contacted than those aged 15–19 years (63% versus 70%
STI/BV among Young People in South Africa
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of those with an attempted visit, P = 0.01) and less likely to be eligible after contact was made
(mostly due to migration). Men were less likely to be contacted than women (58% versus 75%,
P< 0.001). Overall, there was strong evidence that individuals who were sampled but did not
enrol were more likely to be older, male, and from rural or urban areas, and to have completed
secondary education or above, compared with those who enrolled (S1 Table).
Fig 1. Flow diagram for enrolment in a population-based sexually transmitted infection survey among young people aged 15–24 years in rural Kwa-Zulu Natal.
1Not visited: no visit was made to the household because the study ended. 2Not contacted: at least 1 visit was made to the household, but either a parent (if selected
individual<18 years) or the individual was unavailable. 3Ineligible: individuals who were found to have out-migrated from the health and demographic surveillance site
(N = 73 women and 53 men) or who were not capable of providing consent (N = 6 women and 4 men). 4Individuals who were interested in the study, but could not
enrol because study ended.
https://doi.org/10.1371/journal.pmed.1002512.g001
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Of those enrolled, 96% of women provided all vaginal swabs and 93% provided blood sam-
ples; all men provided urine samples and 98% provided blood samples. Both men and women
reported that it was easy to understand how to collect urine and vaginal swabs, respectively
(Fig 2A). Participants agreed they felt comfortable, in control, relaxed, and confident of their
ability to collect the sample correctly (Fig 2B). Participants disagreed that sampling was pain-
ful. Most men disagreed that they felt anxious or embarrassed, and over half of women dis-
agreed that they were anxious or embarrassed (Fig 2C).
Of those who provided samples, 206/245 (84%) of individuals aged 15–19 years and 184/
192 (96%) of individuals aged 20–24 years enrolled had access to a telephone to receive results.
Of those, the majority preferred a telephone call for both positive and negative results (59%
and 57%, respectively), followed by an SMS message (37% and 39%, respectively). Few chose
to receive their results (positive or negative) by WhatsApp message (4% and 4%, respectively).
These results were similar by sex and age, although a higher proportion of males than females
preferred to receive their results by telephone (S2 Table).
Fifty-five participants had1 curable STI and were invited to the clinic for management:
52 (95%) came on their own, and 3 had to be traced.
Results of behavioural questionnaire
Most participants were currently enrolled in school (Table 1). Few participants were working
(11% of men and 5% of women). Proportionally, more men aged 20–24 years reported having
ever smoked a cigarette compared to women of the same age (17% versus 8%, respectively).
Conversely, proportionally fewer men compared to women reported having ever had at least 1
drink of alcohol (23% versus 51%, respectively). A small proportion of participants reported
cannabis use: 8% among men aged 20–24 years and 4% among women of the same age. Few
participants reported using other drugs (1%).
In all, 51% of men reported circumcision: younger men were more likely to be circumcised
(Table 1). Sixteen percent of women reported using intravaginal cleansing; older women were
more likely to report intravaginal cleansing. In all, 23% of women aged 15–19 years and 50%
of women aged 20–24 years reported use of any type of contraception.
In all, 61 (33%) men and 155 (63%) women reported having had sexual intercourse; of
these, the median (IQR) number of lifetime partners was 4 (2–6) for men and 3 (2–3) for
women. A larger proportion of men than women reported having used a condom at last inter-
course (58% versus 41%, respectively). A smaller proportion of men than women reported
knowing their last partner’s HIV status (37% versus 55%, respectively), and a smaller propor-
tion of men than women reported discussing their own HIV status with their last partner (48%
of men versus 63% of women).
More women aged 20–24 years reported providing (32%) or receiving oral sex (46%) than
men of the same age group (12% and 13%, respectively). Few participants reported ever having
anal sex, and fewer men than women (1% versus 5%). Among men who participated in the
2016 HIV serosurvey, the prevalence of laboratory-diagnosed HIV among those aged 15–19
years was 4% and among those aged 20–24 years was 19%. Among women, the prevalence of
laboratory-diagnosed HIV among those aged 15–19 years was 9% and among those aged 20–
24 years was 30%.
Prevalence of STIs/BV
Weighted prevalence from Table 2 shows a high prevalence of chlamydia in men aged 20–24
years (12.6%; 95% CI 6.4%–23.3%) and women in both age groups (15–19 years: 11.7%; 95%
CI 6.8%–19.3%; 20–24 years: 10.2%; 95% CI 6.0%–16.9%). The prevalence of gonorrhoea was
STI/BV among Young People in South Africa
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low, from 0 cases among men aged 20–24 years to 3.2% (95% CI 1.2%–8.2%) in women of the
same age group. There was 1 case of active syphilis—the overall prevalence of active syphilis
was 0.1%. There were 5 TPHA−/VDRL+ samples. The prevalence of trichomoniasis was lower
in men compared with women (0.6% [95% CI 0.1%–4.0%] versus 4.6% [95% CI 2.6%–7.9%]);
the highest prevalence was among women aged 20–24 years. In all, 14% of individuals had a
curable STI (chlamydia, gonorrhoea, syphilis, or trichomoniasis). Of these, 75% reported no
symptoms. The prevalence of HSV-2 was lower in men compared with women (16.8% [95%
CI 11.3%–24.1%] versus 28.7% [95% CI 23.3%–34.7%]), with the highest prevalence among
women aged 20–24 years. The prevalence of BV was 41.1% (95% CI 32.3%–50.5%) among
women aged 15–19 years and 44.2% (95% CI 35.5%–53.2%) among women aged 20–24 years.
Prevalence weighted for sampling and non-response (Table 2) was similar to unweighted prev-
alence and prevalence using sampling weights only (S3 Table).
Factors associated with STIs/BV
In the adjusted analysis of factors associated with curable STIs (chlamydia, gonorrhoea, syphi-
lis, and trichomoniasis), participants aged 20–24 years and women had more than twice the
odds of having a curable STI compared to participants aged 15–19 years and men, respectively
(Table 3). Having a higher number of lifetime sexual partners was associated with having a
curable STI (P = 0.038). Reporting having had sexual intercourse was strongly associated with
having a curable STI.
In the adjusted analysis of factors associated with HSV-2, participants aged 20–24 years and
women had twice the odds of HSV-2 infection compared to participants aged 15–19 years and
men, respectively (Table 4). Participants currently enrolled in school or working had less than
half the odds of HSV-2 infection compared to those who were neither in school nor working.
In the adjusted analysis of factors associated with BV, there was weak evidence that being
currently enrolled in school or working was associated with a diagnosis of BV (Table 5). Those
having ever drunk alcohol had twice the odds of a diagnosis of BV, and there was weak evi-
dence that having ever smoked a cigarette was associated with a diagnosis of BV. Indepen-
dently, those reporting genital touching and having ever had sex had twice the odds of a
diagnosis of BV. Participants who were HSV-2 seropositive had 4 times the odds of a diagnosis
of BV.
In the subgroup analysis among participants who reported having had sex, there was some
evidence that discussing the last partner’s HIV status was associated with not having a curable
STI (adjusted OR 0.48; 95% CI 0.23–1.00; S4 Table). There was no evidence that factors
included in this subgroup analysis were associated with either HSV-2 infection or diagnosis of
BV (S5 and S6 Tables).
Discussion
We conducted a nested STI survey among young people aged 15 to 24 years in a rural HDSS in
KwaZulu-Natal, and found it to be feasible and acceptable. The HDSS provided infrastructure
Fig 2. Box and whisker plots of the acceptability of sampling in a population-based sexually transmitted
infection/bacterial vaginosis survey among young people aged 15–24 years in rural KwaZulu-Natal. The vertical
line within the box indicates the median, the boundaries of the box indicate the interquartile range (25th and 75th
percentiles), and the whiskers indicate values that are within 1.5 times the interquartile range above the 75th percentile,
or 1.5 times the interquartile range below the 25th percentile. Values outside that range are plotted as individual points,
e.g., the medians for (A) equal 0. (A) Ease of understanding the study and instructions, and the ease of sample
collection. (B) Experience of self-collecting urine (males) or vaginal swabs (women)—positive items. (C) Experience of
self-collecting urine (males) or vaginal swabs (women)—negative items.
https://doi.org/10.1371/journal.pmed.1002512.g002
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Table 1. Baseline characteristics of participants in a population-based sexually transmitted infection survey among young people aged 15–24 years in rural Kwa-
Zulu-Natal (N = 447).
Characteristic1 Male Female Overall
15–19 years
(N = 124)
20–24 years
(N = 64)
Total (N =
188)
15–19 years
(N = 124)
20–24 years
(N = 135)
Total (N =
259)
15–19 years
(N = 248)
20–24 years
(N = 199)
Total (N =
447)
Highest level of education
Primary 16 (12.9%) 3 (4.7%) 19 (10.1%) 5 (4.0%) 9 (6.7%) 14 (5.4%) 21 (8.5%) 12 (6.0%) 33 (7.4%)
Secondary 90 (72.6%) 21 (32.8%) 111
(59.0%)
106 (85.5%) 52 (38.5%) 158
(61.0%)
196 (79.0%) 73 (36.7%) 269
(60.2%)
Matriculation or above2 18 (14.5%) 40 (62.5%) 58 (30.9%) 13 (10.5%) 74 (54.8%) 87 (33.6%) 31 (12.5%) 114 (57.3%) 145
(32.4%)
Socioeconomic status3
Low 53 (42.7%) 27 (42.2%) 80 (42.6%) 57 (46.3%) 60 (44.8%) 117
(45.5%)
110 (44.5%) 87 (43.9%) 197
(44.3%)
Middle 30 (24.2%) 18 (28.1%) 48 (25.5%) 24 (19.5%) 38 (28.4%) 62 (24.1%) 54 (21.9%) 56 (28.3%) 110
(24.7%)
High 41 (33.1%) 19 (29.7%) 60 (31.9%) 42 (34.2%) 36 (26.9%) 78 (30.4%) 83 (33.6%0 55 (27.8%) 138
(31.0%)
Currently in school 114 (91.9%) 30 (46.9%) 144
(76.6%)
112 (90.3%) 47 (35.1%) 159
(61.6%)
226 (91.1%) 77 (38.9%) 303
(67.9%)
Working 12 (9.8%) 8 (12.5%) 20 (10.7%) 7 (5.6%) 7 (5.2%) 14 (5.4%) 19 (7.7%) 15 (7.5%) 34 (7.6%)
Ever smoked a cigarette 3 (2.5%) 11 (17.2%) 14 (7.5%) 13 (10.6%) 11 (8.1%) 24 (9.3%) 16 (6.5%) 22 (11.1%) 38 (8.6%)
Ever used cannabis 1 (0.8%) 5 (7.8%) 6 (3.2%) 8 (6.5%) 5 (3.7%) 13 (5.0%) 9 (3.6%) 10 (5.0%) 19 (4.3%)
Ever used other drugs 2 (1.6%) — 2 (1.1%) 1 (0.8%) 2 (1.5%) 3 (1.2%) 3 (1.2%) 2 (1.0%) 5 (1.1%)
Ever drank 1 drink of
alcohol
26 (21.7%) 17 (26.6%) 43 (23.4%) 57 (47.1%) 73 (54.5%) 130
(51.0%)
83 (34.4%) 90 (45.5%) 173
(39.4%)
Ever been circumcised 71 (57.3%) 25 (39.1%) 96 (51.1%) — — — — — —
Ever cleansed inside vagina — — — 13 (10.7%) 28 (20.9%) 41 (16.1%) — — —
Ever had sex 29 (23.6%) 32 (52.5%) 61 (33.2%) 54 (46.2%) 101 (77.7%) 155
(62.8%)
83 (34.6%) 133 (69.6%) 216
(50.1%)
Current use of any
contraception
— — — 27 (22.5%) 67 (50.4%) 94 (37.2%) — — —
Condom at last sex 16 (55.2%) 20 (60.6%) 36 (58.1%) 26 (49.1%) 36 (36.4%) 62 (40.8%) 42 (51.2%) 56 (42.4%) 98 (45.8%)
Last partner discussed his/
her HIV status
8 (27.6%) 13 (44.8%) 21 (36.2%) 25 (46.3%) 60 (61.2%) 85 (55.9%) 33 (39.8%) 73 (57.5%) 106
(50.5%)
Knew last partner’s HIV
status
9 (31.0%) 13 (43.3%) 22 (37.3%) 28 (49.1%) 59 (59.0%) 87 (55.4%) 37 (43.0%) 72 (55.4%) 109
(50.5%)
Discussed your HIV status
with last partner
12 (50.0%) 14 (46.7%) 26 (48.1%) 28 (53.8%) 62 (68.9%) 90 (63.4%) 40 (52.6%) 76 (63.3%) 116
(59.2%)
Number of current sexual
partners
None 94 (78.3%) 29 (49.2%) 123
(68.7%)
63 (57.3%) 29 (23.2%) 92 (39.1%) 157 (68.3%) 58 (31.5%) 215
(51.9%)
1 21 (17.5%) 21 (35.6%) 42 (23.5%) 44 (40.0%) 91 (72.8%) 135
(57.4%)
65 (28.3%) 112 (60.9%) 177
(42.8%)
2 or more 5 (4.2%) 9 (15.3%) 14 (7.8%) 3 (2.7%) 5 (4.0%) 8 (3.4%) 8 (3.5%) 14 (7.6%) 22 (5.3%)
Oral sex, received 12 (9.7%) 8 (12.9%) 20 (10.8%) 21 (17.5%) 59 (46.1%) 80 (32.3%) 33 (13.5%) 67 (35.3%) 100
(23.0%)
Oral sex, provided 9 (7.3%) 7 (11.5%) 16 (8.7%) 11 (9.2%) 38 (30.2%) 49 (19.9%) 20 (8.2%) 45 (24.1%) 65 (15.1%)
Ever had anal sex 2 (1.6%) — 2 (1.1%) 6 (5.0%) 6 (4.7%) 12 (4.8%) 8 (3.3%) 6 (3.2%) 14 (3.2%)
Violence, perpetrator 5 (4.1%) 3 (4.9%) 8 (4.4%) 3 (2.6%) 8 (6.2%) 11 (4.3%) 8 (3.4%) 11 (5.8%) 19 (4.4%)
Violence, victim 8 (6.5%) 3 (4.8%) 11 (5.9%) 7 (5.8%) 19 (15.1%) 26 (10.5%) 15 (6.1%) 22 (11.7%) 37 98.7%)
HIV status4
Positive 2 (3.6%) 5 (19.2%) 7 (8.5%) 6 (8.6%) 23 (29.5%) 29 (19.6%) 8 (6.4%) 28 (26.9%) 36 (15.7%)
(Continued)
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and a sampling frame to carry out a population-based cross-sectional study of STI/BV preva-
lence. There was a high burden of STIs/BV in this high HIV prevalence setting. Most of the
infections were asymptomatic and would not have been identified or treated using national
syndromic management guidelines.
This study is a proof of concept that STI surveys can be successfully conducted within
HDSS networks such as the INDEPTH Network [12], the Network for Analysing Longitudinal
Table 1. (Continued)
Characteristic1 Male Female Overall
15–19 years
(N = 124)
20–24 years
(N = 64)
Total (N =
188)
15–19 years
(N = 124)
20–24 years
(N = 135)
Total (N =
259)
15–19 years
(N = 248)
20–24 years
(N = 199)
Total (N =
447)
Negative 54 (96.4%) 21 (80.8%) 75 (91.5%) 64 (91.4%) 55 (70.5%) 119
(80.4%)
118 (93.6%) 76 (73.1%) 194
(84.3%)
Data given as N (percent).
1Proportions of individuals who responded to study questions (excluding those who preferred not to answer).
2Matriculation is the qualification received upon graduating from high school, and is the minimum requirement for entrance to university.
3Socioeconomic status from a household-level asset index constructed based on ownership of 27 common household items and housing construction, using principal
component analysis. Derived from linking the annual health and demographic surveillance site household-level survey in 2015/2016.
4Linked to HIV test result among individuals who participated in the 2016 serosurvey.
https://doi.org/10.1371/journal.pmed.1002512.t001
Table 2. Prevalence of STIs weighted for sampling and non-response in a population-based STI survey among young people aged 15–24 years in rural KwaZulu-
Natal (N = 447).
STI Male Female All participants
15–19 years
(N = 124)
20–24 years
(N = 64)
All males
(N = 188)
15–19 years
(N = 124)
20–24 years
(N = 135)
All females
(N = 259)
15–19 years
(N = 248)
20–24 years
(N = 199)
All participants
(N = 477)
Chlamydia
Positive 1.6% (0.4–
6.1)
12.6% (6.4–
23.3)
5.3% (3.0–
9.4)
11.7% (6.8–
19.3)
10.2% (6.0–
16.9)
11.2% (7.5–
16.4)
6.2% (3.8–
10.1)
11.5% (7.4–
17.5)
8.1% (5.8–11.1)
Gonorrhoea
Positive 2.3% (0.7–
7.1)
0 1.5% (0.5–
4.7)
1.1% (0.3–
4.5)
3.2% (1.2–
8.2)
1.8% (0.8–
4.1)
1.8% (0.7–
4.3)
1.5% (0.6–
3.9)
1.7% (0.8–3.3)
Syphilis
Active 0 0 0 0 0.8% (0.1–
5.8)
0.3% (0.0–
2.1)
0 0.4% (0.1–
2.7)
0.1% (0.0–0.9)
Early/previously treated 0 1.2% (0.2–
8.5)
0.4% (0.1–
3.0)
0 3.3% (1.2–
8.4)
1.1% (0.4–
3.0)
0 2.2% (0.9–
5.3)
0.8% (0.3–1.8)
Trichomoniasis
Positive 0 1.7% (0.2–
11.1)
0.6% (0.1–
4.0)
2.0% (0.5–
7.7)
9.4% (5.4–
16.0)
4.6% (2.6–
7.9)
0.9% (0.2–
3.6)
5.3% (3.0–
9.2)
2.4% (1.4–4.2)
HSV-2
Positive 12.1% (7.3–
19.2)
25.8%
(14.3–41.9)
16.8%
(11.3–24.1)
18.1% (11.8–
26.8)
48.0% (39.2–
56.9)
28.7% (23.3–
34.7)
14.8% (10.7–
20.1)
36.1% (28.4–
44.6)
22.2% (18.2–26.8)
Bacterial vaginosis
Intermediate — — — 9.9% (5.5–
17.2)
11.3% (6.8–
18.3)
10.4% (6.8–
15.4)
— — —
Positive — — — 41.1% (32.3–
50.5)
44.2% (35.5–
53.2)
42.1% (35.5–
49.0)
— — —
Data given as percent (95% CI).
HSV-2, herpes simplex virus type 2; STI, sexually transmitted infection.
https://doi.org/10.1371/journal.pmed.1002512.t002
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Table 3. Factors associated with chlamydia, gonorrhoea, syphilis and trichomoniasis in a population-based STI survey among young people aged 15–24 years in
rural KwaZulu-Natal (N = 447).
Factor Number with any curable STI/
N (%)
Crude OR (95% CI); P
value
Age- and sex-adjusted OR (95% CI);
P value
Adjusted OR1 (95% CI); P
value
Sociodemographics
Age group P< 0.001 P = 0.001 P = 0.001
15–19 years 20/245 (8.2%) 1 1.00 (1.00–1.00) 1
20–24 years 40/191 (20.9%) 2.98 (1.68–5.30) 2.64 (1.47–4.73) 2.64 (1.47–4.73)
Sex P = 0.001 P = 0.006 P = 0.006
Male 14/188 (7.4%) 1 1 1
Female 46/248 (18.5%) 2.83 (1.50–5.32) 2.45 (1.29–4.65) 2.45 (1.29–4.65)
In school or working P = 0.001 P = 0.268 P = 0.268
No 29/128 (22.7%) 1 1 1
Yes 31/308 (10.1%) 0.38 (0.22–0.67) 0.69 (0.35–1.33) 0.69 (0.35–1.33)
Socioeconomic status2 P = 0.276 P = 0.287 P = 0.287
Low 32/192 (16.7%) 1 1 1
Middle 14/109 (12.8%) 0.74 (0.37–1.45) 0.68 (0.34–1.36) 0.68 (0.34–1.36)
High 14/133 (10.5%) 0.59 (0.30–1.15) 0.61 (0.30–1.21) 0.61 (0.30–1.21)
Highest level of education
completed
P = 0.485 P = 0.774 P = 0.774
Primary 5/33 (15.2%) 1 1 1
Secondary 32/263 (12.2%) 0.78 (0.28–2.15) 0.79 (0.27–2.31) 0.79 (0.27–2.31)
Matriculation or above3 23/140 (16.4%) 1.10 (0.38–3.15) 0.68 (0.22–2.07) 0.68 (0.22–2.07)
Behaviour
Ever smoked a cigarette P = 0.718 P = 0.915 P = 0.827
No 54/395 (13.7%) 1 1 1
Yes 6/38 (15.8%) 1.18 (0.47–2.97) 1.05 (0.41–2.68) 0.90 (0.34–2.35)
Ever drank alcohol P = 0.014 P = 0.150 P = 0.150
No 27/259 (10.4%) 1 1 1
Yes 32/169 (18.9%) 2.01 (1.15–3.49) 1.54 (0.86–2.75) 1.54 (0.86–2.75)
Sexual behaviour and violence
Genital touching P = 0.001 P = 0.044 P = 0.296
No 24/258 (9.3%) 1 1 1
Yes 36/178 (20.2%) 2.47 (1.42–4.31) 1.82 (1.02–3.26) 1.48 (0.71–3.09)
Oral sex, received P = 0.106 P = 0.963 P = 0.201
No 39/326 (12.0%) 1 1 1
Yes 18/98 (18.4%) 1.66 (0.90–3.05) 0.98 (0.51–1.91) 0.62 (0.30–1.29)
Oral sex, provided P = 0.156 P = 0.850 P = 0.626
No 45/357 (12.6%) 1 1 1
Yes 12/62 (19.4%) 1.66 (0.82–3.36) 1.07 (0.51–2.26) 0.83 (0.38–1.79)
Ever had sex P< 0.001 P = 0.004 P = 0.009
No 13/210 (6.2%) 1 1 1
Yes 45/210 (21.4%) 4.13 (2.16–7.92) 2.77 (1.38–5.55) 2.67 (1.28–5.55)
Number of lifetime sexual
partners
P< 0.001 P = 0.014 P = 0.038
None 13/210 (6.2%) 1 1 1
1 17/82 (20.7%) 3.96 (1.83–8.60) 2.81 (1.25–6.33) 2.78 (1.19–6.50)
2 or more 23/104 (22.1%) 4.30 (2.08–8.91) 2.88 (1.32–6.28) 2.47 (1.07–5.70)
Violence, perpetrator P = 0.681 P = 0.891 P = 0.395
No 53/399 (13.3%) 1 1 1
(Continued)
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Population-based HIV/AIDS data on Africa (ALPHA Network) [25], the Department of Sci-
ence and Technology (DST), and the South African Medical Research Council (SAMRC)
South African Population Research Infrastructure Network (SAPRIN) [26] (Fig 3). STI surveys
can be conducted within the infrastructure of HDSSs with 2 important advantages. First, STI
surveys can be carried out in LMICs intermittently to contribute to estimates of the global bur-
den of STIs and to evaluate local implementation of global STI control programmes at a popu-
lation level. Second, STI surveys can be carried out more frequently in settings with high HIV/
STI prevalence to monitor and evaluate enhanced STI/HIV control programmes. HDSS net-
works could provide a strategic platform to strengthen STI surveillance and control in LMICs,
especially in sub-Saharan Africa, where HIV and STI/BV prevalence are high. Importantly,
while population-based data are crucial for an effective STI prevention and control pro-
gramme, these data must be complemented by robust data from high-risk groups (e.g., female
sex workers) to account for STI transmission dynamics that depend on high rates of partner
change [27].
The prevalence of chlamydia was high in this STI survey among women of both age groups
and among men aged 20–24 years. Several studies report high prevalence of chlamydia in
South Africa [6,28–31]; both Microbicide Trials Unit (MTN)–003 (VOICE) and HIV Preven-
tion Trials Network (HPTN) 055 showed higher baseline chlamydia prevalence and incidence
among women in South Africa compared with other sites in the multi-site studies. Sub-
regional or national differences in STI epidemics among young people could be further eluci-
dated in STI surveys in a network of HDSSs. Aetiological diagnosis of STIs is unaffordable and
inaccessible for most LMICs. Rapid, accurate, and affordable point-of-care tests might bridge
this gap in future [32]. The development of tools such as these must be carried out in parallel
with population-based STI surveys and analyses of risk factors.
Although HSV-2 and BV are not curable STIs, better control tools are needed for them, and
we recommend continued integration of HSV-2 and BV in STI prevalence surveys. The preva-
lence of HSV-2 in our study was almost twice as high for young women as for young men, and
almost 50% in women aged 20–24 years. Rapid acquisition of HSV-2 after sexual debut has
been reported in several studies [8,10], suggesting that HSV-2 seropositivity could be used as a
biological proxy for sexual activity. Over 40% of women in this study had BV, consistent with
other studies in sub-Saharan Africa [32]. Factors associated with BV in our study (sexual
debut, currently having more than 1 sex partner, and HSV-2 infection) are consistent with the
Table 3. (Continued)
Factor Number with any curable STI/
N (%)
Crude OR (95% CI); P
value
Age- and sex-adjusted OR (95% CI);
P value
Adjusted OR1 (95% CI); P
value
Yes 3/18 (16.7%) 1.31 (0.37–4.66) 1.10 (0.29–4.09) 0.49 (0.09–2.55)
Violence, victim P = 0.006 P = 0.040 P = 0.126
No 45/387 (11.6%) 1 1 1
Yes 10/35 (28.6%) 3.04 (1.37–6.74) 2.39 (1.04–5.49) 1.96 (0.83–4.65)
1Sociodemographic variables adjusted for age and sex. Behavioural variables adjusted for age, sex, and ever drank alcohol. Sexual behaviour and violence variables
adjusted for age, sex, ever drank alcohol, ever had sex, and having been a violence victim. Number of lifetime sexual partners was not included for the adjustment with
sexual behaviour due to collinearity with ever had sex. Excludes those who preferred not to answer.
2Socioeconomic status from a household-level asset index constructed based on ownership of 27 common household items and housing construction, using principal
component analysis. Derived from linking the annual health and demographic surveillance site household-level survey in 2015/2016.
3Matriculation is the qualification received upon graduating from high school, and is the minimum requirement for entrance to university.
OR, odds ratio; STI, sexually transmitted infection.
https://doi.org/10.1371/journal.pmed.1002512.t003
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Table 4. Factors associated with HSV-2 in a population-based sexually transmitted infection survey among young people aged 15–24 years in rural Kwa-Zulu Natal
(N = 4191).
Factor Number with HSV-2/N
(%)
Crude OR (95% CI); P
value
Age- and sex-adjusted OR (95% CI); P
value
Adjusted OR2 (95% CI); P
value
Sociodemographics
Age group P< 0.001 P< 0.001 P = 0.004
15–19 years 35/233 (15.0%) 1 1 1
20–24 years 73/186 (39.2%) 3.65 (2.30–5.82) 3.29 (2.05–5.28) 2.23 (1.29–3.83)
Sex P< 0.001 P = 0.001 P = 0.006
Male 29/183 (15.8%) 1 1 1
Female 79/236 (33.5%) 2.67 (1.65–4.32) 2.28 (1.39–3.74) 2.03 (1.22–3.37)
In school or working P< 0.001 P = 0.003 P = 0.003
No 57/125 (45.6%) 1 1 1
Yes 51/294 (17.3%) 0.25 (0.16–0.40) 0.44 (0.25–0.75) 0.44 (0.25–0.75)
Socioeconomic status3 P = 0.437 P = 0.550 P = 0.691
Low 51/184 (27.7%) 1 1 1
Middle 29/105 (27.6%) 1.00 (0.58–1.70) 0.92 (0.52–1.62) 0.85 (0.47–1.52)
High 28/129 (21.7%) 0.72 (0.43–1.23) 0.73 (0.42–1.28) 0.79 (0.45–1.39)
Highest level of education
completed
P = 0.007 P = 0.413 P = 0.743
Primary 9/31 (29.0%) 1 1 1
Secondary 51/251 (20.3%) 0.62 (0.27–1.44) 0.59 (0.24–1.45) 0.72 (0.28–1.80)
Matricuation or above4 48/137 (35.0%) 1.32 (0.56–3.09) 0.76 (0.30–1.93) 0.70 (0.27–1.80)
Behaviour
Ever smoked a cigarette P = 0.289 P = 0.488 P = 0.400
No 96/381 (25.2%) 1 1 1
Yes 12/36 (33.3%) 1.48 (0.71–3.08) 1.31 (0.61–2.80) 1.40 (0.64–3.04)
Ever drank alcohol P = 0.009 P = 0.244 P = 0.204
No 52/250 (20.8%) 1 1 1
Yes 52/161 (32.3%) 1.82 (1.16–2.85) 1.34 (0.82–2.18) 1.38 (0.84–2.27)
Sexual behaviour and violence
Genital touching P< 0.001 P = 0.001 P = 0.255
No 42/247 (17.0%) 1 1 1
Yes 66/172 (38.4%) 3.04 (1.93–4.78) 2.24 (1.39–3.61) 1.40 (0.78–2.52)
Oral sex, received P = 0.008 P = 0.741 P = 0.503
No 73/314 (23.2%) 1 1 1
Yes 35/94 (37.2%) 1.96 (1.20–3.21) 1.10 (0.63–1.90) 0.82 (0.46–1.47)
Oral sex, provided P = 0.022 P = 0.577 P = 0.859
No 81/343 (23.6%) 1 1 1
Yes 23/61 (37.7%) 1.96 (1.10–3.48) 1.19 (0.64–2.22) 0.94 (0.49–1.81)
Ever had sex P< 0.001 P = 0.004 P = 0.012
No 31/204 (15.2%) 1 1 1
Yes 76/201 (37.8%) 3.39 (2.11–5.47) 2.14 (1.27–3.58) 1.96 (1.16–3.32)
Number of lifetime sexual
partners
P< 0.001 P = 0.035 P = 0.085
None 31/204 (15.2%) 1 1 1
1 21/78 (26.9%) 2.06 (1.10–3.86) 1.40 (0.72–2.73) 1.29 (0.65–2.56)
2 or more 39/100 (39.0%) 3.57 (2.05–6.21) 2.22 (1.21–4.06) 2.01 (1.08–3.73)
Violence, perpetrator P = 0.791 P = 0.558 P = 0.394
No 102/386 (26.4%) 1 1 1
(Continued)
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literature [32]. Despite BV not being considered a traditional STI, there is an accumulating
body of evidence suggesting that sexual transmission is an integral part of its pathogenesis
[32]. In addition, BV is associated with serious sequelae, including preterm delivery and
increased risk of STI and HIV acquisition and transmission of HIV [3,33–37].
Population-based demographic and behavioural data are also important for planning and
evaluating STI prevention and control programmes [38]. In this HIV hyperendemic setting, it
is reassuring that there was a higher prevalence of self-reported circumcision among the youn-
ger men than among the older men—suggesting the population impact of male medical cir-
cumcision programmes. However, the extremely low self-reported condom use at last sex is a
tremendous concern. In addition, few participants knew their last partner’s HIV status. In this
STI survey, current enrolment in school or working was protective for HSV-2 and BV. These
data mirror findings from the AHRI HDSS, which showed that out-of-school youth reported
earlier sexual debut and more high-risk sex than in-school youth [39], suggesting that inter-
ventions to keep adolescents in school may be just as relevant for other STIs as they are for
HIV [40,41].
Strengths of this study include a high rate of acceptability for participation and sample col-
lection, the success in treating those with a curable STI, and the use of a population-based plat-
form as a sampling frame. There are several challenges for carrying out home-based studies,
including contacting young people during school hours and the provision of confidential results
to participants; however, we maximised contact by modifying the field work hours from 11:00
to 19:00 from Tuesday to Saturday, and provided participants with a choice of mode for receiv-
ing results. Once contacted, enrolment into a population-based study of STI/BV testing was
acceptable among young people, as was the home-based collection of samples, including the
self-collection of genital samples. An additional strength of this study is that it was conducted in
an area with persistently high HIV incidence and prevalence. Results of this study could help to
inform co-strategies to address both HIV and STIs that synergise the transmission of HIV.
This study was not without limitations. The sample collection period was limited to 3.5
months by the start of the next HDSS surveillance round, and we did not reach our target of
800 young people. The smaller sample size of 447 provided less precision for prevalence esti-
mates and less power to investigate factors associated with STIs/BV. In addition, the overall
coverage in the survey was low, increasing the potential for selection bias. It was challenging to
find young men aged 20–24 years at home. HPTN 017 (PopART), a cluster-randomised
Table 4. (Continued)
Factor Number with HSV-2/N
(%)
Crude OR (95% CI); P
value
Age- and sex-adjusted OR (95% CI); P
value
Adjusted OR2 (95% CI); P
value
Yes 4/17 (23.5%) 0.86 (0.27–2.69) 0.70 (0.21–2.33) 0.59 (0.18–1.98)
Violence, victim P = 0.102 P = 0.400 P = 0.532
No 94/373 (25.2%) 1 1 1
Yes 13/34 (38.2%) 1.84 (0.89–3.81) 1.40 (0.64–3.08) 1.29 (0.58–2.83)
1Number less than 447 due to the number of samples collected for testing for HSV-2.
2Sociodemographic variables adjusted for age, sex, and in school/working. Behaviour variables adjusted for age, sex, and in school/working. Sexual behaviour and
violence variables adjusted for age, sex, in school/working, and ever had sex. Number of lifetime sexual partners was not included for the adjustment with sexual
behaviour due to collinearity with ever had sex. Excludes those who preferred not to answer.
3Socioeconomic status from a household-level asset index constructed based on ownership of 27 common household items and housing construction, using principal
component analysis. Derived from linking the annual health and demographic surveillance site household-level survey in 2015/2016.
4Matriculation is the qualification received upon graduating from high school, and is the minimum requirement for entrance to university.
HSV-2, herpes simplex virus type 2; OR, odds ratio.
https://doi.org/10.1371/journal.pmed.1002512.t004
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Table 5. Factors associated with BV in young women in a population-based STI survey among young people aged 15–24 years in rural Kwa-Zulu Natal (N = 2391).
Factor Number with BV/N (%) Crude OR (95% CI); P value Age-adjusted OR (95% CI); P
value
Adjusted OR2 (95% CI); P
value
Sociodemographics
Age group P = 0.640 P = 0.640 P = 0.469
15–19 years 49/119 (41.2%) 1 1 1
20–24 years 53/120 (44.2%) 1.13 (0.68–1.89) 1.13 (0.68–1.89) 0.79 (0.42–1.49)
In school or working P = 0.059 P = 0.050 P = 0.050
No 45/89 (50.6%) 1 1 1
Yes 57/150 (38.0%) 0.60 (0.35–1.02) 0.52 (0.27–1.00) 0.52 (0.27–1.00)
Socioeconomic status3 P = 0.092 P = 0.090 P = 0.128
Low 54/107 (50.5%) 1 1 1
Middle 24/60 (40.0%) 0.65 (0.34–1.24) 0.64 (0.34–1.23) 0.61 (0.31–1.16)
High 24/70 (34.3%) 0.51 (0.27–0.95) 0.51 (0.28–0.96) 0.56 (0.30–1.06)
Highest level of education
completed
P = 0.582 P = 0.643 P = 0.816
Primary 7/13 (53.8%) 1 1 1
Secondary 60/148 (40.5%) 0.58 (0.19–1.83) 0.59 (0.19–1.87) 0.73 (0.22–2.39)
Matriculation or above4 35/78 (44.9%) 0.70 (0.21–2.27) 0.69 (0.21–2.26) 0.68 (0.20–2.24)
Behaviour
Ever smoked a cigarette P = 0.027 P = 0.027 P = 0.104
No 87/215 (40.5%) 1 1 1
Yes 15/23 (65.2%) 2.76 (1.12–6.79) 2.77 (1.13–6.82) 2.19 (0.85–5.61)
Ever drank alcohol P = 0.012 P = 0.014 P = 0.009
No 39/114 (34.2%) 1 1 1
Yes 61/121 (50.4%) 1.96 (1.16–3.31) 1.94 (1.15–3.29) 2.04 (1.19–3.48)
Ever cleansed inside vagina P = 0.569 P = 0.545 P = 0.861
No 88/200 (44.0%) 1 1 1
Yes 14/36 (38.9%) 0.81 (0.39–1.67) 0.80 (0.38–1.66) 0.93 (0.44–1.99)
Use hormonal contraception P = 0.425 P = 0.467 P = 0.876
No 84/202 (41.6%) 1 1 1
Yes 18/37 (48.6%) 1.33 (0.66–2.69) 1.30 (0.64–2.66) 1.06 (0.49–2.29)
Sexual behaviour and violence
Genital touching P < 0.001 P< 0.001 P = 0.021
No 36/122 (29.5%) 1 1 1
Yes 66/117 (56.4%) 3.09 (1.81–5.27) 3.12 (1.82–5.35) 2.12 (1.12–4.02)
Oral sex, received P = 0.014 P = 0.013 P = 0.682
No 57/158 (36.1%) 1 1 1
Yes 39/73 (53.4%) 2.03 (1.16–3.57) 2.11 (1.17–3.82) 1.16 (0.58–2.31)
Oral sex, provided P = 0.068 P = 0.077 P = 0.936
No 71/186 (38.2%) 1 1 1
Yes 23/43 (53.5%) 1.86 (0.95–3.63) 1.86 (0.94–3.71) 0.97 (0.45–2.11)
Ever had sex P < 0.001 P< 0.001 P = 0.031
No 22/85 (25.9%) 1 1 1
Yes 74/143 (51.7%) 3.07 (1.71–5.52) 3.43 (1.85–6.38) 2.14 (1.07–4.27)
Number of lifetime sexual partners P = 0.003 P = 0.001 P = 0.261
None 22/85 (25.9%) 1 1 1
1 31/64 (48.4%) 2.69 (1.35–5.36) 2.93 (1.45–5.93) 1.79 (0.82–3.90)
2 or more 31/60 (51.7%) 3.06 (1.52–6.17) 4.02 (1.85–8.73) 1.91 (0.78–4.69)
Violence, perpetrator P = 0.636 P = 0.654 P = 0.555
(Continued)
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controlled trial offering home-based HIV counselling and testing in South Africa and Zambia,
also reported that young men (32.7%) more often than young women (20.2%) were not at
home at the time of visits [42]. Furthermore, many young people were not at home due to
migration. The AHRI individual surveys of residents aged 17–49 years indicate that approxi-
mately one-fifth of men and women in any survey round have migrated at least once in the last
2 years, and persons with a recent migration history have a higher risk of HIV infection [43];
thus, those with a recent migration history are likely to have a different risk profile. The AHRI
HDSS was established in a highly mobile population with a severe HIV epidemic, in which
characterisation of migration and mobility was central to its conceptual and data model [44].
Indeed, nesting STI surveys in HDSSs may offer another advantage over one-off de novo STI
prevalence surveys: the HDSS sampling frame has information about those who are not
enrolled into the study. Additionally, while a one-time survey will miss some of those who
have migrated; annual repeat cross-sectional surveys ensure that most age-eligible household
members contribute data over time. Reassuringly, STI/BV prevalence weighted for both sam-
pling and non-response data was very similar to the unweighted prevalence or prevalence
weighted for sampling only.
Another limitation was that there was evidence of underreporting of sexual behaviours: 6%
of participants with a curable STI and 15% of participants with HSV-2 reported never having
had sex. Underreporting of sexual behaviour is common, especially among adolescents [45].
We used a computer-assisted survey instrument, study nurses were sex-matched, and
Table 5. (Continued)
Factor Number with BV/N (%) Crude OR (95% CI); P value Age-adjusted OR (95% CI); P
value
Adjusted OR2 (95% CI); P
value
No 92/217 (42.4%) 1 1 1
Yes 5/10 (50.0%) 1.36 (0.38–4.83) 1.34 (0.37–4.81) 1.52 (0.38–6.14)
Violence, victim P = 0.960 P = 0.990 P = 0.585
No 88/205 (42.9%) 1 1
Yes 10/23 (43.5%) 1.02 (0.43–2.44) 1.01 (0.42–2.43) 1.30 (0.51–3.30)
STIs
HSV-2 P < 0.001 P< 0.001 P< 0.001
Negative 50/152 (32.9%) 1 1 1
Positive 49/74 (66.2%) 4.00 (2.22–7.20) 4.52 (2.40–8.50) 4.08 (2.03–8.19)
N. gonorrhoeae/C. trachomatis P = 0.044 P = 0.044 P = 0.768
Negative 84/209 (40.2%) 1 1 1
Positive 18/30 (60.0%) 2.23 (1.02–4.87) 2.23 (1.02–4.88) 1.15 (0.46–2.89)
T. vaginalis P = 0.989 P = 0.944 P = 0.287
Negative 96/225 (42.7%) 1 1 1
Positive 6/14 (42.9%) 1.01 (0.34–3.00) 0.96 (0.32–2.91) 0.51 (0.15–1.77)
1Number less than 447 due to the number of samples collected for testing for BV.
2Sociodemographic variables adjusted for age and in school/working. Behaviour variables adjusted for age, in school/working, and ever drank alcohol. Sexual behaviour
and violence variables adjusted for age, in school/working, ever drank alcohol, genital touching, and ever had sex. STI variables adjusted for age, in school/working, ever
drank alcohol, genital touching, ever had sex, and HSV-2. Number of lifetime sexual partners was not included for the adjustment with sexual behaviour due to
collinearity with ever had sex. Excludes those who preferred not to answer.
3Socioeconomic status from a household-level asset index constructed based on ownership of 27 common household items and housing construction, using principal
component analysis. Derived from linking the annual health and demographic surveillance site household-level survey in 2015/2016.
4Matriculation is the qualification received upon graduating from high school, and is the minimum requirement for entrance to university.
BV, bacterial vaginosis; HSV-2, herpes simplex virus type 2; OR, odds ratio; STI, sexually transmitted infection.
https://doi.org/10.1371/journal.pmed.1002512.t005
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interviews were conducted in a private location to improve the completeness and accuracy of
self-reported sexual behaviour [16,46], but underreporting was still a challenge. Further
research is needed to assess factors affecting the validity of self-reported behaviours among
adolescents [47,48]. Importantly, underreporting of sexual behaviour highlights the need to
have more robust biological measures of sexual risk, such as STI prevalence.
Finally, this survey is limited to the STIs we tested for—future surveys should consider sur-
veillance of Mycoplasma genitalium infection and N. gonorrhoeae resistance in this population.
In addition, surveillance of HPV infection and receipt of vaccination may be important to eval-
uate implementation of HPV vaccination programmes.
In conclusion, the global population of adolescents and young people is increasing, particu-
larly in sub-Saharan Africa. STIs, including incident HIV, cluster in this population, especially
among women. The principles of ‘epidemiology synergy’ between STIs and HIV strongly
Fig 3. Maps illustrating networks of health and demographic surveillance sites (HDSSs) at the global, regional, and national level. (A) International Network for the
Demographic Evaluation of Populations and their Health (INDEPTH Network), a network of 48 members and 7 associate members in 21 low- and middle-income
countries in Africa, Asia, and Oceania conducting population-based surveillance of the health status of communities (modified from http://www.indepth-network.org/
member-centres). (B) Network for Analysing Longitudinal Population-based HIV/AIDS data on Africa (ALPHA Network), a network of 10 centres in sub-Saharan Africa
conducting population-based HIV surveillance (modified from http://alpha.lshtm.ac.uk/partner-study-institutions/). (C) South African Population Research
Infrastructure Network (SAPRIN), an expanding network of HDSSs in South Africa (modified from http://saprin.mrc.ac.za/nodes.html). AHRI, Africa Health Research
Institute; KZN, KwaZulu-Natal.
https://doi.org/10.1371/journal.pmed.1002512.g003
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suggest that STI control must be addressed if HIV is to be brought under effective control [49].
Population-based, representative prevalence estimates of STIs should be complemented by
robust prevalence estimates in key populations to gain a full understanding of the burden of
STIs and the impact of interventions. Without robust prevalence estimates, moving an interna-
tional STI agenda forward will continue to be a challenge. Nesting STI prevalence surveys in
HDSSs could provide an efficient strategy for obtaining these data.
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